CLINICAL_TRIALS
trial_result
· 2025-11-24
Clinical Trial Update: A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
Summary
A Phase 1 clinical trial of CT0991 for relapsed/refractory acute myeloid leukemia has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: He Huang | Conditions: Relapsed/Refractory Acute Myeloid Leukemia(AML) | Phase 1 | Status: SUSPENDED